Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
BIOMARIN PHARMACEUTICAL INC | EVP, Chief R&D Officer | Common Stock | 29.1K | $2.47M | $84.90 | Sep 30, 2024 | Direct |
BIOMARIN PHARMACEUTICAL INC | EVP, Chief R&D Officer | Stock Option (Right to Buy Common Stock) | 49.9K | Sep 30, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BMRN | BIOMARIN PHARMACEUTICAL INC | Sep 30, 2024 | 3 | $0 | 4 | Oct 1, 2024 | EVP, Chief R&D Officer |
BMRN | BIOMARIN PHARMACEUTICAL INC | Sep 30, 2024 | 0 | $0 | 3 | Oct 1, 2024 | EVP, Chief R&D Officer |